 | Up a level |
Number of items: 1.
Clark, RE 
ORCID: 0000-0002-1261-3299 and Clark RE, Polydoros F, Apperley JF, Milojkovic D, Rothwell K, Po,
(2019)
Initial reduction of therapy improves the chance of successful complete treatment discontinuation in chronic myeloid leukaemia: Final results of the British DESTINY Study.
Lancet Haematology.